SKLB06329
SKLB06329 is a potent and selective inhibitor of type I PRMTs. It demonstrates strong selectivity for PRMT6 (IC50= 3.86 nM) without significantly inhibiting type II/III PRMTs (such as PRMT5/7) or various protein lysine methyltransferases [PKMTs]. SKLB06329 effectively suppresses the proliferation of triple-negative breast cancer [TNBC] cells, induces apoptosis, and inhibits the expression of asymmetric dimethylarginine [ADMA] within cells. This compound is applicable for research related to triple-negative breast cancer.
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC043135-500 1x 500 µL
Human IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker) (IGHM/3135R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
PKSH032813-01 10 µg
Recombinant Human CD159a/KLRC1 Protein (His Tag)
Sign In for Pricing
View Details PKSH032813-02 50 µg
Recombinant Human CD159a/KLRC1 Protein (His Tag)
Sign In for Pricing
View Details 
